ST8SIA4 and cancer: In ESCC, increased sialylation mediated by ST8SIA4 can enhance the metastatic potential of cancer cells by promoting cell adhesion, migration, and invasion through interactions with sialoglycan-binding lectins, such as Siglecs and selectins [30, 31].